The CNBC host said that he has reminded his viewers repeatedly that when the Fed is your “enemy” you should stick to ...

The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...

Here is our list of the 15 unhealthiest countries in Europe. Insider Monkey Score: 14.5 ...

Researchers attempt to identify 15 Medicare Part D drugs with the highest risk of facing the U.S. government's ...

People who take Novo Nordisk's semaglutide-based injectables Ozempic and Wegovy seem to be way less likely to die from ...

Plus the week included a stop in Detroit by Lael Brainard, the director of the National Economic Council, who spoke to the ...

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top ...

In this Saturday version of Insider Today, we're talking about Austin, Texas' real estate cycle and the price of weight-loss ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...

The controversy surrounding Ozempic, a popular diabetes medication turned weight-loss solution, has exploded as victims of severe side effects unite to file lawsuits against its manufacturers, Novo ...

Investors have circled back to healthcare stocks this year, and they’re likely to stick around. If they came for the ...

Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.